22:28 on October 7, 2021, Beijing time, OTC market in the United StatesWUHAN GENERAL GP (WUHN.us)The stock changed, and the share price soared by 15.59%. As of press time, the stock was trading at US $0.500 per share, with a turnover of 5000 shares, a turnover rate of 0.01% and an amplitude of 11.61%.
Recent earnings data show that the stock achieved operating income of $2362.00, net profit of-$281603.00, earnings per share of-$0.01a, gross profit of $419.00, and a price-to-earnings ratio of-60.95 times.
In terms of agency rating, there is currently no agency to make "buy, hold, sell" recommendations on the stock.
The pharmaceutical industry in which WUHAN GENERAL GP shares are listed on the US OTC market rose 1.5 per cent as a whole. Among its related stocksJupiter Wellness Inc、Alimera Sciences Inc、China SXT Pharmaceuticals, Inc.The increase is relatively large, Jupiter Wellness Inc,Tilray Inc、Sonoma Pharmaceuticals IncRelatively active, with turnover rates of 7.19%, 2.85% and 1.68%, respectively. The related stocks with larger amplitudes are Jupiter Wellness Inc,Alpha Teknova, Inc.And Alimera Sciences Inc, the amplitudes are 12.41%, 8.59% and 7.91%, respectively.
About WUHAN GENERAL GP in American OTC Market: M2Bio Sciences Inc, formerly known as WUHAN GENERAL GP Group (China) Co., Ltd., is an alternative pharmaceutical company dedicated to the application of emerging technologies and clinical research and health applications of cannabinol (CBD)-based drugs in the human and pet care industries in Canada, the United States, Europe and Australia for cancer, cardiovascular disease, and mental illness. Chronic pain and other diseases. It provides medical-grade CBD products and quality patient care.
(the above content is completed by Money Call, a self-selected intelligent machine writer, and is only used as a reference for users to look at the market, not as a basis for transaction. )